echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Xu Jianqing's team and collaborator "Nature Immunology" reveal a new mechanism for virus-specific CD4+ T cell immune memory maintenance

    Xu Jianqing's team and collaborator "Nature Immunology" reveal a new mechanism for virus-specific CD4+ T cell immune memory maintenance

    • Last Update: 2022-01-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

     Immune memory is a hallmark feature of adaptive immunity


     On December 23, 2021, Professor Xu Jianqing from our hospital, the team of Professor Ye Lilin from the Army Military Medical University and Professor Yin Zhinan from the Institute of Translational Medicine of Jinan University published the title The kinase complex mTORC2 promotes the longevity of virus-specific memory CD4+ T cells on Nature Immunology .


     The researchers first established acute viral infection through lymphocytic choriomeningitis virus (LCMV), combined with bone marrow chimera model (BMC), in the memory CD4 T cell establishment phase (Day 21) and maintenance phase (Day 41), by knocking out Rictor gene to block mTORC2 signal, it is found that mTORC2 signal blocking will lead to a significant reduction of virus-specific memory CD4 T cells


     The death of iron was first defined by the team of Professor Brent Stockwell of Columbia University in 2012


     In terms of mechanism, researchers found that memory CD4 T cells maintain a relatively low but continuous (tonic) mTORC2 signal activity under the influence of the IL-7/IL-7R signaling pathway


     In summary, this study reveals for the first time the role and mechanism of the mTORC2 pathway in the long-term maintenance of memory CD4 T cells.


     The corresponding authors are Professor Ye Lilin from the Institute of Immunology of Army Military Medical University, Professor Yin Zhinan from the Institute of Translational Medicine of Jinan University, and Professor Xu Jianqing from the Institute of Biomedicine, Fudan University


    Original link: https://doi.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.